Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Standard Biotools

Biotech & Life Sciences · Boston, United States · Founded 1999 · IPO 2011 Thoroughbred

Biotech tools company that creates microfluidic-based chips and instrumentation for biological research

Valuation
$205M
Market cap · May/2026
Revenue
$85M
Latest reported FY

Investors

15 investors on Standard Biotools's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 15 investors entered at this stage
Smallcap World Fund
Lilly Ventures
Versant Ventures
Lehman Brothers
Cross Creek Advisors
Cross Creek
Alloy Ventures
InterWest Partners
Invus
EDBI
Bio*One Capital
GE Equity
Wasatch Advisors
Fidelity Contrafund
EuclidSR Partners

Global footprint

Where Standard Biotools has talent and traffic

Workforce by country
20 countries with
team presence
🇺🇸 United States46%
🇨🇦 Canada27.9%
🇸🇬 Singapore8.9%
🇬🇧 United Kingdom4%
🇫🇷 France2.9%
Top 5 of 20 shown
Web traffic by country
17K monthly visits
across markets
🇺🇸 United States31.2%
🇨🇦 Canada26.5%
🇬🇧 United Kingdom9.4%
🇮🇳 India7.6%
🇯🇵 Japan7.1%
Top 5 markets shown

Market sentiment

What the market is saying about Standard Biotools

An AI-synthesized read of the highest-engagement posts about Standard Biotools on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Standard Biotools on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.